Introduction
To survive in a world with limited resources microorganisms have developed elaborate mechanisms such as the formation of biofilms and the production of antimicrobial toxins. A plethora of new antimicrobial agents have been discovered via the elucidation of the chemical compounds used in this bacterial warfare. Indeed, natural products directly from bacterial sources account for the majority of currently employed antibiotics. 1 Despite having complex structure, these compounds are sources of chemical diversity and leads arising from them are often more bio-friendly, due to their co-evolution with the target sites in biological systems.
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Result and Discussion
Due to its intriguing structure and unique bioactivity, we planned to develop a stereoselective synthesis of 1, which may, in principle, have a value in the preparation of promysalin itself as well as various analogues.
The molecule, which can be retrosynthetically disconnected at the ester bond, appears well suited to a convergent synthetic approach based around a salicyldehydroproline core (A) and a dihydroxymyristamide fragment (B) (Scheme 1). We envisaged that the most straightforward approach for preparation of the dehydroproline moiety of fragment (A) could be a lactam reduction by Superhydride ® (lithium triethylborohydride solution), followed by in situ dehydration of the resulting lactamol with TFAA and DIPEA, according to Yu's procedure. 4 As the absolute configuration at the three stereogenic centers had not been established in the original paper, we initially focused on the synthesis of a diastereoisomer arbitrarily chosen with the (S)-configuration at C16, by assuming the natural (S)-configuration of the proline core in the biosynthetic pathway. 1 Thus, (S)-pyroglutamic acid ethyl ester 2 was used as a chiral synthon for construction of the dehydroproline core (Scheme 2). We planned to acylate the lactam with a suitably protected salicylic acid before the reduction.
The choice of the phenolic protecting group proved to be nontrivial, as it affected the outcome of the reductive elimination step. In fact, every attempt to use O-acetyl salicyloyl chloride (commercially available) led to the dehydroproline moiety in very poor yield, together with compounds deriving from hydrolysis of the acetate group. Replacement of acetate with allyl, benzyl, or 4-methoxybenzyl ethers led to the decomposition of the starting material. The use of 2-methoxyethoxymethyl (MEM) ether seemed to be more promising, as the MEM protected salicyl-5-oxopyrrolidine underwent smooth reduction to the lactamol, followed by base mediated in situ elimination to the dehydroproline, in good yield.
Having found a suitable protecting group, we proceeded with the synthesis of fragment 5, (Scheme 2). Ethyl (S)-pyroglutamate 2 was acylated with 2-((2-methoxyethoxy) methoxy)benzoic acid 5 using Ghosez's reagent (1-chloro-N,N,2-trimethyl-1-propenylamine) and TEA in toluene 6 to obtain 3 in 82% yield. Lactam reduction of 3 using LiBHEt3 at -78 °C, followed by treatment with TFAA and DIPEA 4 afforded compound 4 in 62% yield. Finally, basic hydrolysis of the ester gave key intermediate 5.
With the salicyldehydroproline fragment in hand, attention was focused on the myristamide framework (B). We conceived that both hydroxy groups at C2 and C8 could be introduced in a stereoselective way using successive the proline-catalysed MacMillan asymmetric α-hydroxylations of carbonyl compounds 7 as key reactions. As the absolute configuration at C2 and C8 was unknown, this method could have the further advantage of providing access to all stereoisomers, by using the appropriate proline as a catalyst. Thus, commercially available octanal 6 was subjected to α-hydroxylation using L-proline and nitrosobenzene in CHCl3 at +4 °C, followed by in situ reduction with NaBH4 and treatment with 16 [α]D 23 = -0.6 (c 1.8, CHCl3). Again, Swern oxidation followed by another α -oxyamination reaction allowed the stereoselective introduction of the hydroxy group at C2 in compound 14. The (R) configuration at this carbon could be safely assumed on the basis of the mechanism of the reaction. 7 The direct oxidation of 1,2 diol 14 to the corresponding α-hydroxycarboxylic acid gave complex mixtures. 17 After various unsuccessful attempts, the sequential protection of primary and secondary alcohol with TBS and TBDPS respectively, followed by selective deprotection and oxidation of the hydroxy group at C1, proved to be the optimal choice. This route allowed us to introduce at C2 a group resistant to the conditions for the deprotection of the OH at C8. Thus, Due to the instability of dehydroproline core in acidic medium, the protecting groups were sequentially removed under mild, aprotic conditions. After several attempts, we found that careful treatment with TiCl4 at -20 °C, 22 followed by TBAF mediated desilylation, gave promysalin (-)-1 with absolute configuration 2R, 8R, 16S.
When this work was in its final stage, Wuest and coworkers 3 published an elegant total synthesis of all promysalin stereoisomers and assigned the absolute configuration (2R, 8R, 16S) to the natural compound.
Wuest's synthesis of the aliphatic chain appears more efficient than ours, giving the 2,8-dihydroxymyristamide moiety in 45% overall yield from 5-hexenoic acid over 6 steps. On the contrary, their approach to the synthesis of the salicyldehydroproline fragment appears less straightforward, requiring 7 steps from methyl salicylate to obtain the SEM-protected acid for coupling with the alcohol moiety.
The combination of the two routes would most likely offer the best pathway to a convergent synthesis of the natural compound and could be easily transposed to a large scale. The combined strategy could also be optimal for the preparation of promysalin analogues for SAR studies and further exploration of the intriguing modes of action of this compound. 
Conclusions
In summary, a total synthesis of the antibiotic Promysalin was designed and carried out. Crucial steps for our strategy included a MacMillan asymmetric α-hydroxylation of carbonyl compounds applied for the construction of the myristamide framework, and a lactam reduction by Superhydride ® to obtain the salicyldehydroproline fragment. Because of the modular nature of the synthesis, work is in progress to prepare analogues for biological evaluation.
Experimental section

General Information
All reagents and solvents were reagent grade or were purified by standard methods before use.
Melting points were determined in open capillaries by a SMP3 apparatus and are uncorrected. 
Experimental procedures and spectroscopic data
Ethyl (S)-1-(2-((2-methoxyethoxy)methoxy)benzoyl)-5-oxopyrrolidine-2-carboxylate (3).
Ghosez's reagent (1-chloro-N,N,2-trimethyl-1-propenylamine) (2.5 mL, 0.02 mol) was added dropwise to a solution of 2-((2-methoxyethoxy)methoxy)benzoic acid 5 (4.1 g, 0.02 mol) in dry dichloromethane (40 mL) at 0 °C under N2 atmosphere. The reaction mixture was stirred at room temperature for 1 h. The solvent was removed in vacuo and the residue was dried under vacuum and used in the next step without purification. In another 2-necked dry flask was placed ethyl Lpyroglutamate (1.4 g, 9.2 mmol) in dry toluene (15 mL) and the solution was cooled to 0 °C. To this was added NEt3 (3.2 mL, 0.02 mol) followed by dropwise addition of the crude acid chloride solution in toluene (15 mL). The reaction mixture was heated at 80 °C for 3 h, and then it was cooled to room temperature and quenched by addition of saturated aqueous NaHCO3 (30 mL).
The organic layer was separated and the aqueous layer was extracted with ethyl acetate (2 × 100 mL). The combined organic extracts were washed with brine (30 mL), dried over anhydrous 
Ethyl (S)-1-(2-((2-methoxyethoxy)methoxy)benzoyl)-2,3-dihydro-1H-pyrrole-2-carboxylate (4).
To a stirred solution of 3 (1.1 g, 3.0 mmol) in dry toluene (22 mL) was added Superhydride ® (3.6 mL, 3.6 mmol, 1 M in THF) at -78 °C under N2 atmosphere. The solution was stirred for 1 h at -78 °C, then DMAP (7 mg, 0.06 mmol) and DIPEA (2.8 mL, 0.02mol) were added, followed
by very slow addition of TFAA (0.5 mL, 3.6 mmol) over 5 min. The reaction mixture was gradually warmed to room temperature and stirred for 3 h. Water (30 mL) was added and the organic layer was separated. The aqueous layer was extracted with ethyl acetate (2 × 75 mL); the combined organic extracts were washed with brine (15 mL), dried over anhydrous Na2SO4 and concentrated in vacuo. The residue was purified using flash column chromatography in 0-50 % 
(S)-1-(2-((2-methoxyethoxy)methoxy)benzoyl)-2,3-dihydro-1H-pyrrole-2-carboxylicacid (5).
A solution of 4 (920 mg, 2.6 mmol) in EtOH (22.5 mL) was cooled to 0 °C. To this was added dropwise a solution of LiOH (166 mg, 3.9 mmol) in water (11.25 mL). After complete addition the reaction mixture was warmed to room temperature and stirred for 5 h. EtOH was removed in vacuo, the aqueous layer was washed with 40 % ethyl acetate in diethyl ether (2 × 25 mL), cooled to 0 °C and acidified using 5% citric acid. The product was extracted using 5% methanol :
dichloromethane (3 × 100 mL). The combined organic extracts were washed with brine (15 mL), dried over anhydrous Na2SO4 and concentrated to afford pyrroline-carboxylic acid 5 (809 mg, 97%) as a pale yellow gummy solid; Rf (5% methanol : dichloromethane) = 0. 
(R)-octane-1,2-diol (7).
A suspension of L-proline (322 mg, 2.8 mmol) in CHCl3 (30 ml) was cooled to 4 °C and stirred for 15 min, then nitrosobenzene (3 g, 0.03 mol) was added in one portion. At this time the solution turned green. To this suspension was added octanal (13.1 ml, 84.0 mmol) in one portion.
The resulting solution was then stirred at 4 °C for 2 h and it turned yellow. The reaction mixture was then added dropwise to an ethanol (25 mL) suspension of NaBH4 (1.05 g, .0.03 mol) at 0 °C.
After 30 min, the reaction was treated with saturated aqueous NaHCO3 (50 mL). The aqueous layer was extracted with dichloromethane (3 ×75 mL); the combined organic extracts were washed with brine, dried over anhydrous Na2SO4, filtered and concentrated in vacuo. To a solution of the oxy-aniline adduct (14.6 g) in EtOH/AcOH (3:1, 156 mL), Zn dust (8.1 g, 0.12 mol) was added portionwise. The resulting suspension was stirred at room temperature for 1 h.
The reaction mixture was filtered through a plug of celite and the residue was washed with ethanol (50 mL); the filtrate was concentrated in vacuo at a temperature <40 °C. The residue was dissolved in ethyl acetate (200 mL) and washed with saturated aqueous NaHCO3 solution (100 mL), brine (50 mL), dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The resulting yellow oil was purified using flash column chromatography (eluent: 20-50% ethyl acetate : hexane) to afford (R)-octane-1,2-diol 7 (3.7 g, 91%) as an off-white sticky solid; Rf 
(R)-2-(4-methoxybenzyloxy)octan-1-ol (9).
A solution of (R)-octane-1,2-diol 7 (7. 
(R)-2-(4-methoxybenzyloxy)octanal (10).
To a stirred solution of oxalyl chloride (8.8 mL, 0.10 mol) in dry dichloromethane (286 mL), was added DMSO (9.7 mL, 0.14 mol) in dry dichloromethane (143 mL) dropwise at -78 °C under N2
atmosphere. Stirring was continued for 15 min, then 9 (9.1 g, 0.03 mol) in dry dichloromethane (143 mL) was added dropwise. After complete addition, the reaction mixture was stirred at -78 °C for 1 h, then NEt3 (47 mL, 0.34 mol) was added dropwise. The reaction mixture was gradually warmed to 0 °C and stirred at this temperature until complete conversion was observed. The mixture was diluted with diethyl ether (50 mL) and poured in cold sat. NaHCO3 (140 mL). The organic layer was separated and the aqueous layer was extracted with diethyl ether (3 × 100 mL).
The combined organic extracts were washed with brine (75 mL), dried over anhydrous Na2SO4 
(R)-Z-8-(4-methoxybenzyloxy)tetradec-6-enyloxy)tert-butyldimethylsilane (11).
To a stirred suspension of TBSO(CH2)6P 
(R)-8-(4-methoxybenzyloxy)tetradec-6-en-1-ol (12).
A solution of TBS ether 11 (9.5 g, 0.02 mol) in anhydrous THF (82 mL) was cooled to 0 °C. TBAF (61 mL, 0.06 mol, 1 M in THF) was added at 0 °C under N2 atmosphere. The reaction mixture was warmed to room temperature and stirred for 1 h. Saturated NH4Cl (125 mL) was added, and the organic layer was separated. The aqueous layer was extracted with ethyl acetate (3 × 150 mL), and the combined organic extracts were washed with brine (80 mL), dried over 
(R)-8-(4-methoxybenzyloxy)tetradec-6-enal (13).
To a stirred solution of oxalyl chloride (4.7 mL, 0.05 mol) in dry dichloromethane (150 mL), a solution of DMSO (5.1 mL, 0.07 mol) in dry dichloromethane (75 mL) was added dropwise at -78 °C under N2 atmosphere and stirred for 15 min. Tetradecanol 12 (6.3 g, 0.02 mol) in dry dichloromethane (75 mL) was added dropwise. After complete addition, the reaction mixture was stirred at -78 °C for 1 h. After addition of NEt3 (25 mL, 0.18 mol), the reaction mixture was gradually warmed to 0 °C and stirred at this temperature until complete conversion was observed.
The mixture was diluted with diethyl ether (50 mL) and poured in cold sat. NaHCO3 (80 mL), the organic layer was separated and aqueous layer was extracted with diethyl ether (3 × 150 mL).
The combined organic extracts were washed with brine (50 mL), dried over anhydrous Na2SO4 and concentrated in vacuo. Purification using flash column chromatography with 0-5% ethyl acetate : hexane gave 13 (5.7 g, 91%) as a colorless oil; Rf (3% ethyl acetate : hexane) = 0.44.
[α]D 23 = +17.8 (c 1.00, CH3OH 
(2R,8R)-8-(4-methoxybenzyloxy)tetradec-6-ene-1,2-diol (14).
A suspension of L-proline (57.6 mg, 0.5 mmol) in CHCl3 (16. 
4.2.11.(2R,8R)-Z-1-((tert-butyldimethylsilyl)oxy)-8-(4-methoxybenzyloxy)tetradec-6-en-2-ol (15).
To a stirred solution of tetradecane 1,2 diol 14 (400 mg, 1.1 mmol) in dry dichloromethane (11 mL) was added imidazole (149 mg, 2.2 mmol), then TBSCl (215 mg, 1.4 mmol) was added portionwise at 0 °C. The reaction mixture was warmed to room temperature and stirred for 6 h, 
4.2.12.(R)-5-((R)-Z-6-((4-methoxybenzyl)oxy)dodec-4-en-1-yl)-2,2,8,8,9,9-hexamethyl-3,3-diphenyl-4,7-dioxa-3,8-disiladecane (16).
A solution of mono TBS ether 15 (518 mg, 1.1 mmol), imidazole (220 mg, 3.2 mmol) in dry DMF (5.4 mL) was cooled to 0 °C. TBDPS-Cl (0.42 mL, 1.6 mmol) was added dropwise at 0 °C.
After complete addition, the reaction mixture was stirred at room temperature under N2
atmosphere for 12 h. TLC showed partial completion of reaction, thus another (302 mg, 1.1 mmol of TBDPS-Cl was added and stirred for further 8 h. The reaction was quenched by addition of ice; the aqueous layer was extracted with diethyl ether (3 × 50 mL), then the combined organic extracts were washed with brine (30 mL), dried over anhydrous Na2SO4 and concentrated in vacuo. The residue was purified using flash column chromatography with 0-3% ethyl acetate: 
4.2.13.(2R,8R)-Z-2-((tert-butyldiphenylsilyl)oxy)-8-((4-methoxybenzyl)oxy)tetradec-6-en-1-ol (17).
A mixture of bis-silyl ether 16 (698 mg, 0.9 mmol) in AcOH/ THF/ H2O 3 : 1: 1 (36 mL) was stirred at room temperature for 36 h. The reaction was quenched by addition of saturated aq.
K2CO3 (50 mL), followed by addition of solid K2CO3. The aqueous layer was extracted with ethyl acetate (2 × 50 mL). The combined organic extracts were washed with brine (30 mL), dried over anhydrous Na2SO4 and concentrated in vacuo. Purification using flash column chromatography with 0-8% Elemental analysis calcd (%) for C38H54O4Si: C 75.70, H 9.03; found: C 75.42, H 9.00.
(2R,8R)-Z-2-((tert-butyldiphenylsilyl)oxy)-8-((4-methoxybenzyl)oxy)tetradec-6-enoic acid (18).
A suspension of 17 (340 mg, 0.6 mmol), NaHCO3 (141 mg, 1.7 mmol) in acetonitrile / water (3. 
(2R,8R)-Z-2-((tert-butyldiphenylsilyl)oxy)-8-((4-methoxybenzyl)oxy)tetradec-6-enamide (19).
A solution of 18 (224 mg, 0.4 mmol), NH4Cl (38 mg, 0.7 mmol) in dry DMF (5 mL) was cooled to 0 °C. HOBT (73 mg, 0.5 mmol) and HBTU (205 mg, 0.5 mmol) were added followed by DIPEA (0.23 mL, 1.4 mmol). The reaction mixture was warmed to room temperature and stirred for 1 h. Ice was added, and then the aqueous layer was extracted with ethyl acetate (2 × 25 mL).
The combined organic extracts were washed with cold brine (3× 10 mL) and dried over Na2SO4.
After removal of the solvent in vacuo, the residue was purified using flash column 
(2R,8R)-2-((tert-butyldiphenylsilyl)oxy)-8-hydroxytetradecanamide (20).
To a solution of 19 (68 mg, 0.11 mmol) in methanol (6 mL) was added 10% Pd/C (20 mg). The suspension was evacuated under vacuum and flushed with H2 gas (4 times). The reaction mixture was stirred under H2 atmosphere for 12 h at room temperature, then filtered through a plug of celite and the residue was washed with ethyl acetate (10 mL 
(7R,13R)-14-amino-13-((tert-butyldiphenylsilyl)oxy)-14-oxotetradecan-7-yl (S)-1-(2-((2-methoxyethoxy)methoxy)benzoyl)-2,3-dihydro-1H-pyrrole-2-carboxylate (21).
To a stirred solution of pyrrolinecarboxylic acid 5 (66 mg, 0.2 mmol) in dry dichloromethane (8 mL) was added EDC (52 mg, 0.3 mmol) and DMAP (5 mg, 0.04 mmol) at 0 °C. A solution of 20 (69 mg, 0.14 mmol) in dichloromethane (2 mL) was added dropwise at 0 °C. The reaction mixture was warmed to room temperature and stirred for 16 h, then it was poured into water (10 mL) and the organic layer was separated. The aqueous layer was extracted with dichloromethane (2 × 25 mL) and the combined organic extracts were washed with brine and dried over anhydrous Na2SO4. The solvent was removed in vacuo and the residue was purified using flash column 
(7R,13R)-14-amino-13-hydroxy-14-oxotetradecan-7-yl-(S)-1-(2-hydroxybenzoyl)-2,3-dihydro-1H-pyrrole-2-carboxylate (1).
To a stirred solution of 21 (28 mg, 0.03 mmol) in dichloromethane (1 mL) was added TiCl4 (0.13 mL, 0.13 mmol, 1 M in dichloromethane) at -20 °C. The reaction mixture was stirred at -20 °C for 10 min; then aqueous ammonia (2 mL) was added. The aqueous layer was extracted with ethyl acetate (2 × 30 mL), and the combined organic extracts were washed with brine (10 mL) and dried over anhydrous Na2SO4. The solvent was removed in vacuo. The crude compound (24 mg) was dissolved in dry THF (1 mL) and cooled to 0 °C. TBAF (0.1 mL, 0.1 mmol, 1 M in THF) was added dropwise. The reaction mixture was warmed to room temperature and stirred for 1 h, then saturated NH4Cl (5 mL) was added. The aqueous layer was extracted with ethyl acetate (2 × 25 mL); and the combined organic extracts were washed with brine (10 mL) and dried over anhydrous Na2SO4. After removal of the solvent in vacuo, the residue was purified using preparative TLC in 5% methanol : dichloromethane) to furnish 1 (10 mg, 70% over two step) as a colorless oil; Rf (3% methanol : dichloromethane) 0. 
